IgE sensitization to inhalant allergens and the risk of airway infection and disease: A population-based study

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

IgE sensitization to inhalant allergens and the risk of airway infection and disease : A population-based study. / Skaaby, Tea; Husemoen, Lise Lotte Nystrup; Thuesen, Betina Heinsbæk; Fenger, Runa Vavia; Linneberg, Allan.

I: PLOS ONE, Bind 12, Nr. 2, e0171525, 2017.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Skaaby, T, Husemoen, LLN, Thuesen, BH, Fenger, RV & Linneberg, A 2017, 'IgE sensitization to inhalant allergens and the risk of airway infection and disease: A population-based study', PLOS ONE, bind 12, nr. 2, e0171525. https://doi.org/10.1371/journal.pone.0171525

APA

Skaaby, T., Husemoen, L. L. N., Thuesen, B. H., Fenger, R. V., & Linneberg, A. (2017). IgE sensitization to inhalant allergens and the risk of airway infection and disease: A population-based study. PLOS ONE, 12(2), [e0171525]. https://doi.org/10.1371/journal.pone.0171525

Vancouver

Skaaby T, Husemoen LLN, Thuesen BH, Fenger RV, Linneberg A. IgE sensitization to inhalant allergens and the risk of airway infection and disease: A population-based study. PLOS ONE. 2017;12(2). e0171525. https://doi.org/10.1371/journal.pone.0171525

Author

Skaaby, Tea ; Husemoen, Lise Lotte Nystrup ; Thuesen, Betina Heinsbæk ; Fenger, Runa Vavia ; Linneberg, Allan. / IgE sensitization to inhalant allergens and the risk of airway infection and disease : A population-based study. I: PLOS ONE. 2017 ; Bind 12, Nr. 2.

Bibtex

@article{862679b795d142149d316a4d9f31c0f8,
title = "IgE sensitization to inhalant allergens and the risk of airway infection and disease: A population-based study",
abstract = "BACKGROUND: Immunoglobulin E (IgE) sensitization, which is the propensity to develop IgE antibodies against common environmental allergens, is associated with a lymphocyte T-helper type 2 (Th2) skewed immune response and a high risk of allergic respiratory disease. Little is known about whether IgE sensitization confers an increased risk of respiratory infections in adults. We investigated the association between IgE sensitization and the incidence of acute airway infections, other infections and chronic lower airway disease events as recorded in nation-wide registries.METHODS: We included 14,849 persons from five population-based studies with measurements of serum specific IgE positivity against inhalant allergens. Participants were followed by linkage to Danish national registries (median follow-up time 11.3 years). The study-specific relative risks were estimated by Cox regression analysis, meta-analysed, and expressed as hazard ratios, HRs (95% confidence intervals, CIs).RESULTS: The relative risks for IgE sensitized vs. non-sensitized were: for pneumonia (HR = 1.20, 95% CI: 1.01, 1.41), other acute airway infection (HR = 0.86, 95% CI: 0.60, 1.22), infection (HR = 1.06, 95% CI: 0.90, 1.24), asthma (HR = 2.26, 95% CI: 1.79, 2.86), and other chronic lower airway disease (HR = 1.31, 95% CI: 1.08, 1.58). In never smokers, the higher risk of pneumonia (HR = 1.73, 95% CI: 1.23, 2.44) and asthma (HR = 3.17, 95% CI: 2.10, 4.76) among IgE sensitized was more pronounced.CONCLUSIONS: IgE sensitization was associated with a higher risk of asthma, other chronic lower airway diseases, and pneumonia. However, the association between IgE sensitization and pneumonia may be explained by undiagnosed asthma causing the pneumonia. Further studies are needed for confirmation.",
author = "Tea Skaaby and Husemoen, {Lise Lotte Nystrup} and Thuesen, {Betina Heinsb{\ae}k} and Fenger, {Runa Vavia} and Allan Linneberg",
year = "2017",
doi = "10.1371/journal.pone.0171525",
language = "English",
volume = "12",
journal = "PLoS ONE",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "2",

}

RIS

TY - JOUR

T1 - IgE sensitization to inhalant allergens and the risk of airway infection and disease

T2 - A population-based study

AU - Skaaby, Tea

AU - Husemoen, Lise Lotte Nystrup

AU - Thuesen, Betina Heinsbæk

AU - Fenger, Runa Vavia

AU - Linneberg, Allan

PY - 2017

Y1 - 2017

N2 - BACKGROUND: Immunoglobulin E (IgE) sensitization, which is the propensity to develop IgE antibodies against common environmental allergens, is associated with a lymphocyte T-helper type 2 (Th2) skewed immune response and a high risk of allergic respiratory disease. Little is known about whether IgE sensitization confers an increased risk of respiratory infections in adults. We investigated the association between IgE sensitization and the incidence of acute airway infections, other infections and chronic lower airway disease events as recorded in nation-wide registries.METHODS: We included 14,849 persons from five population-based studies with measurements of serum specific IgE positivity against inhalant allergens. Participants were followed by linkage to Danish national registries (median follow-up time 11.3 years). The study-specific relative risks were estimated by Cox regression analysis, meta-analysed, and expressed as hazard ratios, HRs (95% confidence intervals, CIs).RESULTS: The relative risks for IgE sensitized vs. non-sensitized were: for pneumonia (HR = 1.20, 95% CI: 1.01, 1.41), other acute airway infection (HR = 0.86, 95% CI: 0.60, 1.22), infection (HR = 1.06, 95% CI: 0.90, 1.24), asthma (HR = 2.26, 95% CI: 1.79, 2.86), and other chronic lower airway disease (HR = 1.31, 95% CI: 1.08, 1.58). In never smokers, the higher risk of pneumonia (HR = 1.73, 95% CI: 1.23, 2.44) and asthma (HR = 3.17, 95% CI: 2.10, 4.76) among IgE sensitized was more pronounced.CONCLUSIONS: IgE sensitization was associated with a higher risk of asthma, other chronic lower airway diseases, and pneumonia. However, the association between IgE sensitization and pneumonia may be explained by undiagnosed asthma causing the pneumonia. Further studies are needed for confirmation.

AB - BACKGROUND: Immunoglobulin E (IgE) sensitization, which is the propensity to develop IgE antibodies against common environmental allergens, is associated with a lymphocyte T-helper type 2 (Th2) skewed immune response and a high risk of allergic respiratory disease. Little is known about whether IgE sensitization confers an increased risk of respiratory infections in adults. We investigated the association between IgE sensitization and the incidence of acute airway infections, other infections and chronic lower airway disease events as recorded in nation-wide registries.METHODS: We included 14,849 persons from five population-based studies with measurements of serum specific IgE positivity against inhalant allergens. Participants were followed by linkage to Danish national registries (median follow-up time 11.3 years). The study-specific relative risks were estimated by Cox regression analysis, meta-analysed, and expressed as hazard ratios, HRs (95% confidence intervals, CIs).RESULTS: The relative risks for IgE sensitized vs. non-sensitized were: for pneumonia (HR = 1.20, 95% CI: 1.01, 1.41), other acute airway infection (HR = 0.86, 95% CI: 0.60, 1.22), infection (HR = 1.06, 95% CI: 0.90, 1.24), asthma (HR = 2.26, 95% CI: 1.79, 2.86), and other chronic lower airway disease (HR = 1.31, 95% CI: 1.08, 1.58). In never smokers, the higher risk of pneumonia (HR = 1.73, 95% CI: 1.23, 2.44) and asthma (HR = 3.17, 95% CI: 2.10, 4.76) among IgE sensitized was more pronounced.CONCLUSIONS: IgE sensitization was associated with a higher risk of asthma, other chronic lower airway diseases, and pneumonia. However, the association between IgE sensitization and pneumonia may be explained by undiagnosed asthma causing the pneumonia. Further studies are needed for confirmation.

U2 - 10.1371/journal.pone.0171525

DO - 10.1371/journal.pone.0171525

M3 - Journal article

C2 - 28182643

VL - 12

JO - PLoS ONE

JF - PLoS ONE

SN - 1932-6203

IS - 2

M1 - e0171525

ER -

ID: 173158503